Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Bolsa de Valores de Sao Paulo  >  Itaú Unibanco Holding S.A.    ITUB4   BRITUBACNPR1

ITAÚ UNIBANCO HOLDING S.A.

(ITUB4)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory

share with twitter share with LinkedIn share with facebook
08/07/2020 | 06:57pm EDT

SAO PAULO, Aug 7 (Reuters) - Brazilian billionaire Jorge Lemann's foundation and other business interests will fund the building of factory to produce the COVID-19 vaccine being developed by Oxford University and pharmaceutical company AstraZeneca PLC.

The Lemann Foundation said in a statement on Friday that the 100 million reais ($18 million) factory will be donated to Brazil's premier biomedical research and development lab, the Oswaldo Cruz Foundation, or Fiocruz.

It said the factory will be ready to produce 30 million doses of the vaccine per month as of the beginning of 2021.

Brazil is approaching 100,000 deaths from COVID-19 in the world's worst coronavirus outbreak after the United States.

The Brazilian government sees the British vaccine as the most promising of the vaccines that are being developed by researchers worldwide.

The Oxford/AstraZeneca vaccine is being tested on Brazilian volunteers in a study led by the Federal University of São Paulo that is also funded by the Lemann Foundation.

Other donors to the initiative to ensure Brazil can absorb the technology to produce the potential vaccine include Brazilian brewer Ambev SA, Itaú Unibanco, the Votorantim Institute and the Behring Family Foundation.

Lemann said he hoped the initiative will help Brazil be "better positioned and prepared to face other challenges of this nature that may arise."

Brazilian President Jair Bolsonaro issued a decree on Thursday setting aside 1.9 billion reais ($356 million) in funds to purchase an initial 100 million doses of the Oxford/AstraZeneca vaccine and to invest in its eventually production in Brazil.

The health ministry reported on Friday 50,230 new cases of the novel coronavirus and 1,079 deaths from the disease caused by the virus in the past 24 hours.

Brazil has registered 2,962,442 cases of the virus since the pandemic began, while the official death toll from COVID-19 has risen to 99,572, according to ministry data. (Reporting by Eduardo Simoes; Writing by Anthony Boadle; editing by Diane Craft and Marguerita Choy)

Stocks mentioned in the article
ChangeLast1st jan.
AMBEV S.A. -0.47% 12.73 End-of-day quote.-31.82%
ASTRAZENECA PLC 0.36% 8641 Delayed Quote.13.21%
EURO / BRAZILIAN REAL (EUR/BRL) -0.37% 6.3451 Delayed Quote.41.66%
ITAÚ UNIBANCO HOLDING S.A. -0.87% 22.9 End-of-day quote.-38.27%
PREMIER BIOMEDICAL, INC. 44.44% 0.0013 Delayed Quote.225.00%
share with twitter share with LinkedIn share with facebook
All news about ITAÚ UNIBANCO HOLDING S.A.
09/21ITAÚ UNIBANCO S A : Announcement to the Market - Live Panorama Itausa
PU
09/17Brazil's Itau lays off 270 staff in retail units, union says
RE
09/16ITAÚ UNIBANCO S A : Announcement to the Market - Itaú Unibanco achieved 500,000 ..
PU
09/14Global banks left on the sidelines in Brazil's IPO boom
RE
09/11ITAÚ UNIBANCO S A : Announcement to the Market - Itaú CorpBanca
PU
09/10TRADING OF OWN SHARES FOR TREASURY M : August 2020
PU
09/01ITAÚ UNIBANCO HOLDING S.A. : Ex-dividend day for monthly dividend
FA
08/28ITAÚ UNIBANCO S A : Summarized Minutes of the Meeting of the Board of Directors ..
PU
08/19ITAÚ UNIBANCO S A : Reference Form 2019
PU
08/18ITAÚ UNIBANCO S A : Announcement to the Market - Composition of the Audit Commit..
PU
More news
Financials
Sales 2020 114 B 21 094 M 21 094 M
Net income 2020 19 394 M 3 588 M 3 588 M
Net Debt 2020 - - -
P/E ratio 2020 12,5x
Yield 2020 1,91%
Capitalization 218 B 40 139 M 40 420 M
Capi. / Sales 2020 1,92x
Capi. / Sales 2021 1,77x
Nbr of Employees 94 910
Free-Float 53,6%
Chart ITAÚ UNIBANCO HOLDING S.A.
Duration : Period :
Itaú Unibanco Holding S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ITAÚ UNIBANCO HOLDING S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 32,59 BRL
Last Close Price 22,90 BRL
Spread / Highest target 87,8%
Spread / Average Target 42,3%
Spread / Lowest Target 13,5%
EPS Revisions
Managers
NameTitle
Candido Botelho Bracher President & Chief Executive Officer
Roberto Egydio Setúbal Co-Chairman
Pedro Moreira Salles Co-Chairman
Alexsandro Broedel Lopes Executive Director-Finance
Milton Maluhy Filho Chief Financial Officer & Vice President
Sector and Competitors